As the world’s leading microbial genomics company, uBiome uses next generation high-throughput DNA sequencing technology to generate detailed analyses of the human microbiome, the ecosystem of trillions of bacteria which populate the human body, both in and on it.
While most of an individual’s bacteria is found in the gut, there are dozens of other bacteria-harboring sites on the body, most with their own distinct microbial profiles. Individuals can have their own microbiomes tested by uBiome by providing a straightforward self-swabbed sample, returned by mail. Analysis is currently provided for five sites – gut, oral, nose, genitals, and skin.
uBiome was launched in 2012 by scientists and technologists educated at Stanford and UCSF after a crowdfunding campaign raised over $350,000 from citizen scientists, around triple its initial goal. The company is now funded by Andreessen Horowitz, Y Combinator, and other leading investors.